Signum Morning Briefing: Join us on 3 October and discover how increased collaboration between patient associations and the pharma industry can lead to earlier patient diagnosis.

X

Navigate the next 3-5 years in Nordic pharma with expert insights

  • Learn how Real-World Evidence is reshaping regulatory processes and healthcare decision-making.
  • Understand how AI and digitalization are accelerating market access and commercial success.
  • Discover the impact of national budget constraints and the rise of sustainability requirements.

    Whitepapers

    If you’re looking for indepth insights on life science topics, you’ve come to the right place. In our whitepapers we drill down and address current issues. You get thorough analyses based on our own qualitative and quantitative studies. Get in touch if you want to start a dialog.

    Whitepaper The Value of Patient Preference

    The value of patient
    preference

    We explore the growing focus on patient preference evidence and how pharma companies can use patient preference evidence.

    Read whitepaper
    Whitepaper The Rise of Data Science

    The rise of data
    science

    How public healthcare’s rampup of data science solutions is an opportunity for well-prepared commercial pharma organisations

    Read whitepaper
    Whitepaper Beyond Real-World-Evidence

    Beyond real world
    evidence

    This white paper suggests ways of improving utilisation of Real World Data throughout the organisation.

    Read whitepaper

    Forward Thinkers Review 2022

    How to succeed in the Nordic pharma markets. Top experts and key opinion leaders from the Nordic pharma industry share their insights.

    Download report